# MabPlex

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mabplex

- Industry: Pharmaceuticals
- Headquarters: Yantai, China
- Website: www.mabplexinc.com
- Total disclosed funding: $129M
- Latest round: Series B (Jun 8, 2020)
- Investors on record: 13

## About

Established in 2013 and based in Yantai, China, MabPlex Inc. is a CDMO services provider which develops and manufactures biopharmaceuticals mAbs, recombinant proteins, ADCs and bispecifics.

## Funding rounds

- Series B, Jun 8, 2020, $70M — OrbiMed Advisors, Detong Capital, CMS Asset Management, Sunshine Insurance, Horus Capital, SDIC Venture Capital, Qiandao Investment Fund Management, GF Venture Capital, Finnova Capital, Huajin Lingchuang Fund Management, Shandong Financial Development, Zhongcheng Huiying Capital
- Angel, Jan 17, 2019, $59M — SDIC Venture Capital, Shenzhen Capital Real Estate Fund

## Investors

- SDIC Venture Capital (https://capitalatlas.ai/funds/sdic-venture-capital) — Angel, Series B
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Angel
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B
- Detong Capital (https://capitalatlas.ai/funds/detong-capital) — Series B
- CMS Asset Management (https://capitalatlas.ai/funds/cms-asset-management) — Series B
- Sunshine Insurance — Series B
- Horus Capital (https://capitalatlas.ai/funds/horus-capital) — Series B
- Qiandao Investment Fund Management (https://capitalatlas.ai/funds/qiandao-investment-fund-management) — Series B
- GF Venture Capital (https://capitalatlas.ai/funds/gf-venture-capital) — Series B
- Finnova Capital (https://capitalatlas.ai/funds/finnova-capital) — Series B
- Huajin Lingchuang Fund Management (https://capitalatlas.ai/funds/huajin-lingchuang-fund-management) — Series B
- Shandong Financial Development — Series B
- Zhongcheng Huiying Capital — Series B